Suspected other malignancies* | |||
---|---|---|---|
Confirmed other malignancies | n | Not confirmed other malignancies † | n |
9 (4.00%) | 37 (16.4%) | ||
Sites of suspected lesions | |||
Thyroid cancer | 1 | Colon or upper gastrointestinal | 15 |
Lung cancer | 1 | Thyroid | 11 |
Skin cancer | 1 | Head and neck | 4 |
New breast cancer | 1 | Uro-gynecological | 2 |
Peritoneal cancer | 1 | Lung | 2 |
Kidney cancer | 1 | Mesenteric lymph node | 1 |
Malignant melanoma | 1 | Muscle (abdominal wall) | 1 |
Hematological cancer | 1 | Breast | 1 |
Kidney | 1 | ||
Clinical consequences | |||
Biopsy¤ | 8 | Clinical examinations | 16 |
General anesthesia | 7 | Ultrasound | 16 |
Other surgery | 4 | Endoscopy (colon or ventricular) | 14 |
Follow-up CT or [18F]FDG- PET/CT | 4 | Biopsy¤ | 12 |
Blood tests | 4 | Follow-up ultrasound | 9 |
Hospital admission | 3 | Laryngoscopy or cystoscopy | 4 |
Clinical examinations | 3 | Follow-up CT or [18F]FDG-PET/CT | 4 |
Medical treatment | 3 | General anesthesia | 3 |
Thyroidectomy | 2 | Hospital admission | 3 |
Ultrasound | 2 | Other surgery | 2 |
Bone marrow examination | 1 | Blood tests | 2 |
Cryoablation | 1 | MRI | 1 |
Renography | 1 | Endobronchial ultra sound | 1 |
Laryngoscopy | 1 | Thyroidectomy | 1 |
CT urography | 1 | ||
Gynecological examination | 1 | ||
Severe complications | 1 |